ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

IDAMYCIN PFS
Leukemias, lymphomas, and other hematologic cancers
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

REMOVE SELECTED | COMPARE SELECTED

Drug Name:

IDAMYCIN PFS Rx

Generic Name and Formulations:
Idarubicin 1mg/mL; soln for IV infusion; preservative-free.

Company:
Pfizer Inc.

e-Prescribe this drug via Surescripts


Therapeutic Use:

Product Resources »
  • Product Information
  • Coupons, Samples & Vouchers
  • Patient Education and Assistance

Indications for IDAMYCIN PFS:

Acute myeloid leukemia.

Adult Dose for IDAMYCIN PFS:

Give by slow IV infusion (over 10–15 minutes). 12mg/m2 daily for 3 days (in combination with cytarabine). May give 2nd course if needed; if toxicity develops after 1st course, delay until resolved; reduce dose by 25%. Hepatic and renal impairment: consider reduce dose.

Children's Dose for IDAMYCIN PFS:

Not recommended.

See Also:

IDAMYCIN

Pharmacological Class:

Anthracycline.

Warnings/Precautions:

Pre-existing bone marrow suppression. Cardiovascular disease. Thoracic irradiation. Previous anthracycline therapy at high cumulative doses. Renal or hepatic impairment. Monitor CBCs, cardiac, renal and hepatic function prior to and during treatment. Avoid extravasation. Elderly. Pregnancy (Cat.D); avoid use. Nursing mothers: not recommended.

Adverse Reactions:

Myelosuppression, GI upset, mucositis, abdominal pain, alopecia, rash, inj site reactions, hepatotoxicity, renal toxicity, cardiotoxicity (eg, CHF, arrhythmias, chest pain, MI, asymptomatic declines in LVEF), hyperuricemia.

How Supplied:

Single-dose vials—1
PFS: Single-dose vials (5mL, 10mL, 20mL)—1